TARDBP and glycogen storage disease VI: BMAA also appears to induce an increase of several neurodegenerative-disease biomarkers, such as the hyperphosphorylated Tau protein and the presence of neurofibrillary plaques (Parkinson syndrome) or the aggregated form of TDP-43 (ALS).